Description
A RIPK2 inhibitor; inhibits RIPK2 by 65% in a kinase assay at 10 µM; inhibits VEGFR3 by greater than 90%, as well as 14 additional kinases by 60-89% in a panel of 344 kinases at 10 µM; reduces colonic damage in a mouse model of TNBS-induced colitis at 7.5 and 145 mg/kg twice per day; a prodrug
Formal name: 2-[[4-(5-benzothiazolylamino)-6-[(1,1-dimethylethyl)sulfonyl]-7-quinazolinyl]oxy]-ethanol, 1-(dihydrogen phosphate)
Synonyms:
Molecular weight: 538.5
CAS: 1579965-12-0
Purity: ≥98%
Formulation: A crystalline solid